Soparkar Peter — SEC Form 4 filings
SEC reporting owner CIK 1736315. 8 Form 4 filings on record with FilingPulse; latest filed 2025-12-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-14 to 2025-12-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 50,000 shares, $211,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,960 shares, $5,920 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: purchase of 50,000 shares @ $4.22 ($211,000) in Adverum Biotechnologies, Inc., filed 2025-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) | CHIEF OPERATING OFFICER | 8 | 1 leg · 50,000 sh · $211,000 | 1 leg · 2,960 sh · $5,920 | 37 |
Form 4 filings — Soparkar Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-10 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Code (U): 80,189 · Code (U): 13,125 · Grant/award (A): 150,000 @ $0 · Code (U): 157,333 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 64,394 (derivative) · +8 more | EDGAR |
| 2025-12-08 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Purchase (P): 50,000 @ $4.22 | EDGAR |
| 2025-06-20 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 4,074 (derivative) @ $0 · Grant/award (A): 4,074 (derivative) @ $0 · Disposition to issuer (D): 13,999 (derivative) @ $0 · Grant/award (A): 13,999 (derivative) @ $0 · +12 more | EDGAR |
| 2025-05-16 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Sale (S): 2,960 @ $2 | EDGAR |
| 2025-02-27 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 13,125 @ $0 · Grant/award (A): 78,750 (derivative) @ $0 | EDGAR |
| 2024-08-06 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 64,394 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1736315 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →